Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 456
Filter
1.
Sci Adv ; 6(22): eaba6712, 2020 05.
Article in English | MEDLINE | ID: mdl-32524002

ABSTRACT

Droplet microfluidics has become a powerful tool in precision medicine, green biotechnology, and cell therapy for single-cell analysis and selection by virtue of its ability to effectively confine cells. However, there remains a fundamental trade-off between droplet volume and sorting throughput, limiting the advantages of droplet microfluidics to small droplets (<10 pl) that are incompatible with long-term maintenance and growth of most cells. We present a sequentially addressable dielectrophoretic array (SADA) sorter to overcome this problem. The SADA sorter uses an on-chip array of electrodes activated and deactivated in a sequence synchronized to the speed and position of a passing target droplet to deliver an accumulated dielectrophoretic force and gently pull it in the direction of sorting in a high-speed flow. We use it to demonstrate large-droplet sorting with ~20-fold higher throughputs than conventional techniques and apply it to long-term single-cell analysis of Saccharomyces cerevisiae based on their growth rate.


Subject(s)
Microfluidics , Saccharomyces cerevisiae , Electrodes , Microfluidics/methods
3.
Diabet Med ; 33(10): 1399-405, 2016 10.
Article in English | MEDLINE | ID: mdl-26482027

ABSTRACT

AIMS: To test the hypothesis that 1-h plasma glucose in an oral glucose tolerance test is a better predictor of the development of diabetes than 2-h plasma glucose, independently of indices of insulin secretion or action in Japanese adults. METHODS: A historical cohort study was conducted in 1445 Japanese workers who did not have diabetes. The association between 1-h plasma glucose and the development of Type 2 diabetes was analysed. RESULTS: Overall, 95 of the study participants developed Type 2 diabetes during a mean follow-up of 4.5 years. The area under the receiver-operating characteristic curve for 1-h plasma glucose for future diabetes [0.88 (95% CI 0.84-0.91)] was greater than that for 2-h plasma glucose [0.79 (95% CI 0.74-0.84)], and for insulinogenic [0.73 (95% CI 0.68-0.78)] and disposition indices [0.79 (95% CI 0.74-0.84); P < 0.05]. Compared with the first quartile, the hazard ratio for future diabetes in the fourth quartile of 1-h plasma glucose was 42.5 [95% CI 5.7-315.2 (P < 0.05)] and the hazard ratio in the fourth quartile of 2-h plasma glucose was 4.4 [95% CI 1.8-10.8 (P < 0.05)], after adjustments for covariates including fasting plasma glucose. The significance of the elevated hazard ratio in the fourth quartile of 1-h plasma glucose was maintained after adjustments for 2-h plasma glucose, insulinogenic index or disposition index, whereas the elevation of the hazard ratio in the fourth quartile of 2-h plasma glucose was diminished and was no longer significant after adjustments for 1-h plasma glucose. CONCLUSIONS: One-hour plasma glucose had a greater association with the future development of Type 2 diabetes than did 2-h plasma glucose, independently of oral glucose tolerance test-derived indices of insulin action in a Japanese population.


Subject(s)
Blood Glucose/analysis , Diabetes Mellitus, Type 2/diagnosis , Prediabetic State/blood , Prediabetic State/diagnosis , Adult , Asian People , Cohort Studies , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/ethnology , Disease Progression , Female , Follow-Up Studies , Glucose Intolerance/blood , Glucose Intolerance/diagnosis , Glucose Intolerance/ethnology , Glucose Tolerance Test/methods , Humans , Japan , Male , Prediabetic State/ethnology , Predictive Value of Tests , Time Factors
4.
Diabet Med ; 31(5): 552-8, 2014 May.
Article in English | MEDLINE | ID: mdl-24151911

ABSTRACT

AIMS: To investigate whether the elevation of liver enzymes is associated with the progression from normal to impaired glucose tolerance. METHODS: A historical cohort study was conducted in 594 male workers at public schools, who had normal glucose tolerance at baseline. The progression to impaired glucose tolerance and impaired fasting glycaemia during a mean follow-up of 3.1 years was measured using an oral glucose tolerance test. RESULTS: Overall, 141 (23.7%) subjects developed impaired glucose tolerance and 68 (11.4%) subjects developed impaired fasting glycaemia, 23 of whom had combined impaired fasting glycaemia/impaired glucose tolerance. The incidence of impaired glucose tolerance increased significantly with increasing quartiles of serum aspartate aminotransferase, alanine aminotransferase and γ-glutamyltransferase (P for trend <0.01). In Cox proportional hazards regression analysis, after adjusting for comprehensive risk factors, including plasma glucose levels, BMI and homeostatic model assessment of insulin resistance, the risk of progression to impaired glucose tolerance was significantly higher in the highest quartile of alanine aminotransferase than in the lowest quartile (hazard ratio 2.5; 95% CI 1.1-5.7). A significant association between alanine aminotransferase and the progression to impaired glucose tolerance was found after further adjustments for other liver enzymes or after the sample was limited to those with BMI < 25.0 kg/m(2) or with fasting plasma glucose < 5.5 mmol/l. CONCLUSIONS: A higher level of alanine aminotransferase was independently associated with progression from normal to impaired glucose tolerance in Japanese men. The elevation of alanine aminotransferase may be a change that occurs early in the evolution of diabetes.


Subject(s)
Glucose Intolerance/epidemiology , Hyperglycemia/epidemiology , Liver/enzymology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Biomarkers/blood , Blood Glucose/metabolism , Body Mass Index , Cohort Studies , Disease Progression , Follow-Up Studies , Glucose Intolerance/metabolism , Glucose Tolerance Test , Humans , Hyperglycemia/metabolism , Japan/epidemiology , Male , Middle Aged , Prevalence , Risk Factors , gamma-Glutamyltransferase/blood
5.
Article in English | MEDLINE | ID: mdl-24109779

ABSTRACT

Fontan procedure is one of the common surgical treatments of congenital heart diseases. Patients with Fontan circulation have single ventricle in the systemic circulation with the total cavopulmonary connection. We have been developing a pulmonary circulatory assist device using shape memory alloy fibers for Fontan circulation with total cavopulmonary connection. It consisted of the shape memory alloy fibers, the diameter of which are 100 µm. The fibers could wrap the ePTFE conduit for Fontan TCPC connection from the outside. We designed the sequential motion control system for sophisticated pulmonary hemodynamics by the pulsatile flow generation. In order to achieve pulsatile flow assistance in pulmonary arterial system, we fabricated a mechanical structure by sequential contraction of shape memory alloy fibers. Then, we developed a sequential contraction controller for the assist system, which could reproduce the wall contractile velocity at 6.0 to 20.0 cm/sec. We examined hemodynamic characteristic of its function using a mock circulatory system, which consisted of two overflow tanks representing venous and pulmonary arterial pressures in Fontan circulation. As a result, the pulmonary circulation assist device with sequential contraction could achieve effective promotion of the pulsatility in pulmonary arterial flow.


Subject(s)
Fontan Procedure/instrumentation , Heart Defects, Congenital/surgery , Cardiac Surgical Procedures/instrumentation , Child , Heart Defects, Congenital/physiopathology , Heart Ventricles/surgery , Hemodynamics , Humans , Infusion Pumps, Implantable , Myocardial Contraction , Pulmonary Artery/physiopathology , Pulmonary Artery/surgery , Pulmonary Circulation , Pulsatile Flow
6.
Anim Genet ; 43(5): 518-24, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22497247

ABSTRACT

Backfat thickness affects the preservation of the beef carcass after slaughter and confers organoleptic characteristics assessed by the consumer. One of the breeding goals for Canchim, a tropically adapted breed, is to comprehensively increase fat thickness. Our goals were to identify genomic regions associated with backfat in Canchim populations and validate the association of single nucleotide polymorphisms (SNPs) overlapping previously identified QTL regions known to affect fat deposition. Fifteen animals with lower and 15 animals with higher residues for backfat, according to a linear model using the SAS GLM procedure, were selected from a population of 1171 animals and genotyped using the BovineSNP50 BeadChip. Initial analysis revealed more than 100 SNPs that discriminated the tails of phenotypic distribution. One extended region of association included the centromeric region of chromosome (Chr) 14. Because this region overlapped with QTL from previous reports, we developed SNP assays to interrogate two linkage disequilibrium blocks, one in the centromeric region and another in the middle region of Chr 14 to confirm the association. The analysis validated the presence of specific haplotypes affecting fat thickness.


Subject(s)
Adipose Tissue/anatomy & histology , Cattle/anatomy & histology , Cattle/genetics , Genome-Wide Association Study , Polymorphism, Single Nucleotide , Adipose Tissue/diagnostic imaging , Animals , Brazil , Female , Gene Expression Profiling , Haplotypes , Linkage Disequilibrium , Male , Oligonucleotide Array Sequence Analysis , Quantitative Trait Loci , Ultrasonography
7.
Gene Ther ; 19(1): 34-48, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21614029

ABSTRACT

T cells recognize tumor-associated antigens under the condition of lymphopenia-induced homeostatic proliferation (HP); however, HP-driven antitumor responses gradually decay in association with tumor growth. Type I interferon (IFN) has important roles in regulating the innate and adaptive immune system. In this study we examined whether a tumor-specific immune response induced by IFN-α could enhance and sustain HP-induced antitumor immunity. An intratumoral IFN-α gene transfer resulted in marked tumor suppression when administered in the early period of syngeneic hematopoietic stem cell transplantation (synHSCT), and was evident even in distant tumors that were not transduced with the IFN-α vector. The intratumoral delivery of the IFN-α gene promoted the maturation of CD11c(+) cells in the tumors and effectively augmented the antigen-presentation capacity of the cells. An analysis of the cytokine profile showed that the CD11c(+) cells in the treated tumors secreted a large amount of immune-stimulatory cytokines including interleukin (IL)-6. The CD11c(+) cells rescued effector T-cell proliferation from regulatory T-cell-mediated suppression, and IL-6 may have a dominant role in this phenomenon. The intratumoral IFN-α gene transfer creates an environment strongly supporting the enhancement of antitumor immunity in reconstituted lymphopenic recipients through the induction of tumor-specific immunity and suppression of immunotolerance.


Subject(s)
Gene Transfer Techniques , Genetic Therapy/methods , Immune Tolerance , Interferon-alpha/administration & dosage , Lymphopenia/therapy , Adenoviridae/genetics , Adenoviridae/metabolism , Animals , Antigen Presentation , Biomarkers, Tumor/immunology , Biomarkers, Tumor/metabolism , CD11c Antigen/immunology , CD11c Antigen/metabolism , Cell Line, Tumor , Cell Proliferation , Female , Genetic Vectors/genetics , Genetic Vectors/metabolism , Hematopoietic Stem Cell Transplantation , Immunotherapy/methods , Interferon-alpha/genetics , Interferon-alpha/immunology , Interferon-alpha/therapeutic use , Interleukin-6/metabolism , Lymphopenia/genetics , Lymphopenia/immunology , Mice , Mice, Inbred BALB C , Neoplasms, Experimental , Plasmids/genetics , Plasmids/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/immunology
8.
Diabetes Obes Metab ; 14(2): 155-62, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21951301

ABSTRACT

AIMS: Mineralocorticoid receptor (MR) blockade is an effective treatment for hypertension and diabetic nephropathy. There are no data on the effects of MR blockade on diabetic peripheral neuropathy (DPN). The aim of this study was to determine whether MRs are present in the peripheral nerves and to investigate the effectiveness of MR blockade on DPN in streptozotocin (STZ)-induced diabetic rats. METHODS: Expression of MR protein and messenger RNA (mRNA) was examined in the peripheral nerves using Western blot analysis and RT-PCR. We next studied the effects of the selective MR antagonist eplerenone and the angiotensin II receptor blocker candesartan on motor and sensory nerve conduction velocity (NCV), morphometric changes and cyclooxygenase-2 (COX-2) gene and NF-κB protein expression in the peripheral nerves of STZ-induced diabetic rats. RESULTS: Expression of MR protein and mRNA in peripheral nerves was equal to that in the kidney. Motor NCV was significantly improved by 8 weeks of treatment with either eplerenone (39.1 ± 1.2 m/s) or candesartan (46.4 ± 6.8 m/s) compared with control diabetic rats (33.7 ± 2.0 m/s) (p < 0.05). Sensory NCV was also improved by treatment with candesartan or eplerenone in diabetic rats. Eplerenone and candesartan caused significant improvement in mean myelin fibre area and mean myelin area compared with control diabetic rats (p < 0.05). COX-2 mRNA and NF-κB protein were significantly elevated in the peripheral nerves of diabetic rats compared with control rats, and treatment with eplerenone or candesartan reduced these changes in gene expression (p < 0.05). CONCLUSION: MR blockade may have neuroprotective effects on DPN.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/pharmacology , Benzimidazoles/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Diabetic Nephropathies/prevention & control , Mineralocorticoid Receptor Antagonists , Peripheral Nerves/drug effects , Spironolactone/analogs & derivatives , Tetrazoles/pharmacology , Animals , Biphenyl Compounds , Blotting, Western , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetic Nephropathies/metabolism , Diabetic Nephropathies/physiopathology , Eplerenone , Male , Mineralocorticoid Receptor Antagonists/pharmacology , NF-kappa B/metabolism , Peripheral Nerves/physiopathology , RNA, Messenger/metabolism , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Receptors, Mineralocorticoid/genetics , Receptors, Mineralocorticoid/metabolism , Spironolactone/pharmacology
9.
J Int Med Res ; 39(2): 522-7, 2011.
Article in English | MEDLINE | ID: mdl-21672356

ABSTRACT

Ephrin B1 and its cognate receptor, Eph receptor B2, key regulators of embryogenesis, are expressed in human atherosclerotic plaque and inhibit adult human monocyte chemotaxis. Few data exist, however, regarding the gene expression profiles of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells. Gene expression profiles were determined of all 21 members of this gene family in atherosclerosis-related cells by reverse transcription-polymerase chain reaction analysis. The following 17 members were detected in adult human peripheral blood monocytes: EFNA1 and EFNA3 - EFNA5 (coding for ephrins A1 and A3 - A5); EPHA1, EPHA2, EPHA4 - EPHA6 and EPHA8 (coding for Eph receptors A1, A2, A4 - A6 and A8); EFNB1 and EFNB2 (coding for ephrins B1 and B2); and EPHB1 - EPHB4 and EPHB6 (coding for Eph receptors B1 - B4 and B6). THP-1 monocytic cells, Jurkat T cells and adult arterial endothelial cells also expressed multiple EFN and EPH genes. These results indicate that a wide variety of ephrins and Eph receptors might affect monocyte chemotaxis, contributing to the development of atherosclerosis. Their pathological significance requires further study.


Subject(s)
Ephrins/genetics , Gene Expression Profiling , Gene Expression Regulation , Multigene Family/genetics , Plaque, Atherosclerotic/genetics , Plaque, Atherosclerotic/pathology , Receptors, Eph Family/genetics , Adult , Endothelial Cells/metabolism , Ephrins/metabolism , Humans , Jurkat Cells , Monocytes/metabolism , Receptors, Eph Family/metabolism , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction
10.
J Int Med Res ; 39(2): 549-57, 2011.
Article in English | MEDLINE | ID: mdl-21672360

ABSTRACT

Percutaneous coronary intervention (PCI) using a drug-eluting stent (DES) leads to less re-stenosis than PCI using a bare metal stent (BMS), however there is still controversy whether use of a DES for severe coronary disease leads to an acceptable outcome in patients with diabetes mellitus (DM). In this study 8159 lesions were treated in 6739 patients (mean age 68.9 years) with coronary artery disease. Use of a DES significantly decreased the re-stenosis rate compared with BMS in both DM (9.6% versus 21.3%) and non-DM (9.5% versus 17.1%) patients. The re-stenosis rate was significantly higher in DM than in non-DM patients in the BMS group but not in the DES group. There was no statistically significant difference in event-free survival after stenting of patients with left main coronary artery (LMCA) disease between the BMS and DES groups. It was concluded that, compared with BMS, DES reduced re-stenosis in patients with DM, however, we advise careful treatment after using DES for severe coronary disease, including LMCA lesions, in patients with DM.


Subject(s)
Angioplasty, Balloon, Coronary , Coronary Disease/complications , Coronary Disease/therapy , Diabetes Complications/pathology , Stents , Aged , Coronary Angiography , Coronary Disease/diagnostic imaging , Coronary Restenosis/complications , Coronary Restenosis/therapy , Drug-Eluting Stents/adverse effects , Female , Hospitalization , Humans , Kaplan-Meier Estimate , Male , Stents/adverse effects , Treatment Outcome
11.
Article in English | MEDLINE | ID: mdl-22256284

ABSTRACT

Total cavopulmonary connection (TCPC) is commonly applied for the surgical treatment of congenital heart disease such as single ventricle in pediatric patients. Patients with no ventricle in pulmonary circulation are treated along with Fontan algorithm, in which the systemic venous return is diverted directly to the pulmonary artery without passing through subpulmonary ventricle. In order to promote the pulmonary circulation after Fontan procedure, we developed a newly designed pulmonary circulatory assist device by using shape memory alloy fibers. We developed a pulmonary circulatory assist device as a non-blood contacting mechanical support system in pediatric patients with TCPC. The device has been designed to be installed like a cuff around the ePTFE TCPC conduit, which can contract from outside. We employed a covalent type functional anisotropic shape memory alloy fiber (Biometal, Toki Corporation, Tokyo Japan) as a servo actuator of the pulmonary circulatory assist device. The diameter of this fiber was 100 microns, and its contractile frequency was 2-3 Hz. Heat generation with electric current contracts these fibers and the conduit. The maximum contraction ratio of this fiber is about 7% in length. In order to extend its contractile ratio, we fabricated and installed mechanical structural units to control the length of fibers. In this study, we examined basic contractile functions of the device in the mock system. As a result, the internal pressure of the conduit increased to 63 mmHg by the mechanical contraction under the condition of 400 msec-current supply in the mock examination with the overflow tank of 10 mmHg loading.


Subject(s)
Alloys/chemistry , Fontan Procedure/instrumentation , Heart-Assist Devices , Pulmonary Circulation/physiology , Child , Equipment Design , Humans , Mechanical Phenomena , Pressure
13.
J Int Med Res ; 38(1): 253-65, 2010.
Article in English | MEDLINE | ID: mdl-20233537

ABSTRACT

Calcium channel blockers (CCBs) can prevent cardiovascular events in patients with coronary artery disease (CAD). This study looked retrospectively at the prognosis of CAD in hypertensive patients with CAD who had undergone a coronary angiograph, had been given a CCB (benidipine [n = 66], amlodipine [n = 45], or long-acting nifedipine [n = 31]) on hospital discharge and were then followed up for a mean +/- SD of 5.2 +/- 2.9 years. Systolic/diastolic blood pressure for all 142 patients decreased significantly from a mean +/- SD of 137 +/- 20/74 +/- 15 mmHg to 129 +/- 20/71 +/- 12 mmHg. Major adverse cardiovascular events (MACE) occurred in 15 patients. Chronic kidney disease (CKD) was a significant risk factor for MACE (hazard ratio 2.35, 95% confidence intervals 1.45, 3.80). Benidipine was superior to nifedipine in preventing MACE in patients both with and without CKD. In conclusion, benidipine and amlodipine reduced the frequency of MACE in hypertensive patients with CAD, particularly in those with complicating CKD.


Subject(s)
Amlodipine/pharmacology , Calcium Channel Blockers/pharmacology , Coronary Artery Disease/drug therapy , Coronary Artery Disease/etiology , Dihydropyridines/pharmacology , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/drug therapy , Nifedipine/pharmacology , Aged , Blood Pressure/drug effects , Female , Humans , Hypertension/complications , Hypertension/drug therapy , Male , Prognosis , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome
14.
Heredity (Edinb) ; 104(4): 387-92, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20010960

ABSTRACT

Differences in mating time between populations can give rise to premating reproductive isolation. Tephritid fruit flies exhibit large variation in mating time among intra- or inter-specific populations. We previously cloned the clock gene period from two strains of melon fly, Bactrocera cucurbitae; in one the individuals mate early during the day, whereas in the other the individuals mate later. These strains were originally established by divergent artificial selection for developmental time, 'short' and 'long', with early and late mating times, respectively. The deduced amino acid sequences of PERIOD proteins for these two strains were reported to be identical. Here we cloned another clock gene cryptochrome (cry) from the two strains, and found two stable amino acid substitutions in the strains. In addition, the allele frequency at the two polymorphic sites of cry gene correlated with the circadian locomotor period (tau) across strains, whereas the expression pattern of cry mRNA in the heads of flies taken from the short strain significantly differed from that from the long strain. These findings suggest that variation in the cry gene is related to differences in the circadian behaviour in the two strains, thus implying that the cry gene may have an important role in reproductive isolation.


Subject(s)
Cryptochromes/genetics , Sexual Behavior, Animal/physiology , Sexual Maturation/genetics , Tephritidae/genetics , Animals , Base Sequence , CLOCK Proteins/genetics , Female , Gene Expression Regulation, Developmental , Genetic Speciation , Male , Molecular Sequence Data , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Homology, Amino Acid , Sexual Maturation/physiology , Species Specificity , Tephritidae/growth & development , Time Factors
15.
J Int Med Res ; 37(2): 378-84, 2009.
Article in English | MEDLINE | ID: mdl-19383231

ABSTRACT

DNA analyses of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Japanese patients with idiopathic chronic pancreatitis (ICP) were performed to determine the relationship between the CFTR mutation and ICP. The study included patients with alcoholic pancreatitis (n = 20), patients with ICP (n = 20) and healthy volunteers (controls; n = 110). The poly-T region in intron 8 of the CFTR gene was analysed by direct sequencing. The CFTR coding region was screened using single-strand conformational polymorphism and direct sequencing. In the controls, frequencies of the 5T genotype and 5T allele were 4.5% and 3.6%, respectively. The frequency of the 5T genotype was significantly higher in the ICP group (20%) versus controls, but was not significantly different in alcoholic chronic pancreatitis patients (5%). Thus, the CFTR gene mutation, especially the 5T genotype, appears to have some relationship to ICP prevalence in Japanese patients independent of cystic fibrosis.


Subject(s)
Asian People/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Mutation, Missense/genetics , Pancreatitis, Chronic/epidemiology , Pancreatitis, Chronic/genetics , Alleles , Amino Acid Sequence , Base Sequence , Case-Control Studies , Cystic Fibrosis Transmembrane Conductance Regulator/chemistry , DNA Mutational Analysis , Genotype , Humans , Introns/genetics , Japan/epidemiology , Molecular Sequence Data
17.
Clin Exp Immunol ; 152(3): 432-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18422733

ABSTRACT

Mikulicz's disease (MD) is gaining acceptance as an immunoglobulin G4 (IgG4)-related disease characterized by bilateral lacrimal and salivary gland swelling. The aetiology of MD and other IgG4-related diseases is still unclear. The present work was performed to study the clonality of infiltrating IgG4-positive plasma cells in lacrimal glands and circulating peripheral blood cells in patients with MD, and compare the clonal relationship between infiltrating and circulating IgG4 positive cells. Total cellular RNA was extracted from the lacrimal glands and peripheral blood in five MD patients. Reverse transcription polymerase chain reaction was performed with primers specific for activation-induced cytidine deaminase (AID) and for Ig VH and IgG4. Sequences of Ig VH were compared with the structure of Ig VH of the lacrimal glands and the peripheral blood cells. AID was expressed to varying degrees in lacrimal glands of all MD patients. Most IgG4-positive cells infiltrating lacrimal glands and in peripheral blood were polyclonal, although several clonally related pairs were detected. In one patient, two of the circulating IgG4 VH4-59 clones shared identical CDR3 sequences with the clones within the lacrimal glands. In conclusion, while most tissue-infiltrating and circulating IgG4-positive cells in MD are polyclonal, some clonally related IgG4 positive cells exist between lacrimal gland and peripheral blood, accounting for the clinical features of MD as an IgG4-related disease involving multiple organs.


Subject(s)
Immunoglobulin G/analysis , Lacrimal Apparatus/immunology , Lymphocyte Subsets/immunology , Mikulicz' Disease/immunology , Plasma Cells/immunology , Aged , Amino Acid Sequence , Clone Cells/immunology , Complementarity Determining Regions/genetics , Cytidine Deaminase/metabolism , Female , Genes, Immunoglobulin Heavy Chain , Humans , Lacrimal Apparatus/enzymology , Male , Middle Aged , Mikulicz' Disease/enzymology , Mikulicz' Disease/genetics , Molecular Sequence Data , Reverse Transcriptase Polymerase Chain Reaction/methods , Somatic Hypermutation, Immunoglobulin
18.
Heart ; 94(10): 1282-7, 2008 Oct.
Article in English | MEDLINE | ID: mdl-17923468

ABSTRACT

OBJECTIVES: The aim of this study was to investigate left ventricular (LV) function reserve in hypertrophic cardiomyopathy (HCM) patients with and without cardiac troponin gene mutations before transition to the dilated phase. METHODS: LV ejection fraction (EF) was continuously evaluated in 52 patients with non-obstructive HCM during supine ergometer exercise using radionuclide ventricular function monitoring with a cadmium telluride detector (VEST). On the basis of genetic analysis, patients were divided into two groups: 10 with cardiac troponin gene mutations (group A) and 42 without these gene mutations (group B). RESULTS: Exercise duration, peak exercise load, and heart rate during exercise did not differ between the two groups. The differences from baseline to peak exercise ofthe LV end-diastolic volume decreased similarly in the twogroups. In contrast, the difference of the LV end-systolicvolume in group A increased significantly compared withgroup B (17.7% (SD 12.7%) vs 3.4% (SD 13.2%);p=0.0031). Consequently, the difference of LVEF ingroup A decreased significantly in contrast with group B(-14.1% (SD 11.1%) vs -1.2% (SD 11.7%); p=0.0025).Additionally, the changes in LVEF and stroke volumedecreased significantly more in group A than in group B(-22.2% (SD 18.6%) vs -1.1% (SD 17.8%); p=0.0017and -12.9% (SD 21.7%) vs 12.3% (SD 24.4%);p=0.0042, respectively). CONCLUSIONS: These results suggest that HCM patientswith cardiac troponin gene mutations may displayexercise-induced LV systolic dysfunction more frequentlythan HCM patients without this abnormality


Subject(s)
Cardiomyopathy, Hypertrophic/genetics , Exercise/physiology , Mutation/genetics , Troponin I/genetics , Ventricular Dysfunction, Left/genetics , Adult , Aged , Cardiomyopathy, Hypertrophic/physiopathology , Echocardiography , Female , Humans , Male , Middle Aged , Systole/physiology , Ventricular Dysfunction, Left/physiopathology
19.
Clin Pharmacol Ther ; 83(5): 731-9, 2008 May.
Article in English | MEDLINE | ID: mdl-17957184

ABSTRACT

An open, randomized, four-phased crossover study using 4 mg of pitavastatin or 20 mg of atorvastatin was performed to compare their efficacy and safety, especially regarding plasma levels of coenzyme Q10 (CoQ10) in 19 Japanese patients with heterozygous familial hypercholesterolemia. Pitavastatin and atorvastatin caused significant and almost comparable reductions in serum levels of total cholesterol (-35.4 vs. -33.8%), low-density lipoprotein cholesterol (-42.8 vs. -40.7%), and triglyceride (-26.1 vs. -29.4%), and significantly increased serum levels of high-density lipoprotein cholesterol (12.1 vs. 11.4%). Under these conditions, plasma levels of CoQ10 were reduced by atorvastatin (-26.1%, P=0.0007) but not by pitavastatin (-7.7%, P=0.39), although no adverse events or abnormalities of liver and muscle enzyme were observed after either statin treatment. It remains to be seen whether the observed changes in CoQ10 levels are related to the long-term safety of this drug.


Subject(s)
Heptanoic Acids/therapeutic use , Hyperlipoproteinemia Type II/drug therapy , Hyperlipoproteinemia Type II/enzymology , Pyrroles/therapeutic use , Quinolines/therapeutic use , Ubiquinone/analogs & derivatives , Anticholesteremic Agents/adverse effects , Anticholesteremic Agents/therapeutic use , Atorvastatin , Cholesterol/blood , Cholesterol, LDL/blood , Coenzymes/blood , Cross-Over Studies , Female , Heptanoic Acids/adverse effects , Humans , Hyperlipoproteinemia Type II/blood , Male , Middle Aged , Pyrroles/adverse effects , Quinolines/adverse effects , Triglycerides/blood , Ubiquinone/blood
20.
Genet Mol Res ; 6(4): 911-22, 2007 Oct 05.
Article in English | MEDLINE | ID: mdl-18058712

ABSTRACT

An effective strategy for managing protein databases is to provide mechanisms to transform raw data into consistent, accurate and reliable information. Such mechanisms will greatly reduce operational inefficiencies and improve one's ability to better handle scientific objectives and interpret the research results. To achieve this challenging goal for the STING project, we introduce Sting_RDB, a relational database of structural parameters for protein analysis with support for data warehousing and data mining. In this article, we highlight the main features of Sting_RDB and show how a user can explore it for efficient and biologically relevant queries. Considering its importance for molecular biologists, effort has been made to advance Sting_RDB toward data quality assessment. To the best of our knowledge, Sting_RDB is one of the most comprehensive data repositories for protein analysis, now also capable of providing its users with a data quality indicator. This paper differs from our previous study in many aspects. First, we introduce Sting_RDB, a relational database with mechanisms for efficient and relevant queries using SQL. Sting_rdb evolved from the earlier, text (flat file)-based database, in which data consistency and integrity was not guaranteed. Second, we provide support for data warehousing and mining. Third, the data quality indicator was introduced. Finally and probably most importantly, complex queries that could not be posed on a text-based database, are now easily implemented. Further details are accessible at the Sting_RDB demo web page: http://www.cbi.cnptia.embrapa.br/StingRDB.


Subject(s)
Computational Biology/methods , Database Management Systems , Databases, Protein , Proteins/chemistry , Software , Protein Structure, Secondary
SELECTION OF CITATIONS
SEARCH DETAIL
...